CHARACTERIZATION OF CLONED HUMAN CHOLECYSTOKININ-B RECEPTOR AS A GASTRIN RECEPTOR

被引:0
|
作者
MIYAKE, A
MOCHIZUKI, S
KAWASHIMA, H
机构
关键词
CLONED CCK-B RECEPTOR; CHOLECYSTOKININ; GASTRIN; YM022;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The cholecystokinin (CCK)-B receptor cloned from human brain was characterized as a gastrin receptor by using heterologous expression systems of COS-7 cells and Xenopus oocytes. I-125-gastrin binding to human CCK-B receptor expressed in COS-7 was time-dependent, saturable and also specific, as well as (125)-I-CCK-8. The binding of I-125-gastrin was inhibited by CCK-8 about 10-fold more potently than by gastrin. The rank order of potency of several antagonists to I-125-gastrin binding was YM022 > CI-988 > L-365,260 > L-364,718. Addition of GTP gamma S, a nonhydrolysable analog of GTP, dose-dependently inhibited I-125-gastrin binding, and lowered the gastrin binding affinity, Gastrin (10(-9)-10(-7) M) also evoked a Ca2+-dependent Cl- current in Xenopus oocytes expressing CCK-B receptors. These results suggest that the pharmacological profile of the cloned human CCK-B receptor using I-125-gastrin is closely parallel to that reported in gastric mucosa, and that the receptor transduces cellular signals of gastrin as well as those of CCK-8.
引用
收藏
页码:1339 / 1343
页数:5
相关论文
共 50 条
  • [11] Differential expression of gastrin, cholecystokinin-A and cholecystokinin-B receptor mRNA in human pancreatic cancer cell lines
    Monstein, HJ
    Ohlsson, B
    Axelson, J
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2001, 36 (07) : 738 - 743
  • [12] Coexpression of cholecystokinin-B/gastrin receptor and gastrin gene in human gastric tissues and gastric cancer cell line
    Zhou, Jian-Jiang
    Chen, Man-Ling
    Zhang, Qun-Zhou
    Hu, Jian-Kun
    Wang, Wen-Ling
    WORLD JOURNAL OF GASTROENTEROLOGY, 2004, 10 (06) : 791 - 794
  • [13] A novel cholecystokinin-B/gastrin receptor splice variant is expressed in human colon cancers.
    Rui, XL
    Hellmich, HL
    Ehlers, RA
    Fleming, RY
    Evers, BM
    Townsend, CM
    Hellmich, MR
    GASTROENTEROLOGY, 2000, 118 (04) : A533 - A533
  • [14] Cholecystokinin-B/gastrin receptor-targeting peptides for staging and therapy of medullary thyroid cancer and other cholecystokinin-B receptor-expressing malignancies
    Behr, TM
    Béhé, MP
    SEMINARS IN NUCLEAR MEDICINE, 2002, 32 (02) : 97 - 109
  • [15] IDENTIFICATION OF CHOLECYSTOKININ-B GASTRIN RECEPTOR DOMAINS WHICH CONFER HIGH-AFFINITY FOR GASTRIN
    SCHMITZ, F
    WU, MJ
    PRATT, DS
    BEINHORN, M
    KOPIN, AS
    GASTROENTEROLOGY, 1995, 108 (04) : A1004 - A1004
  • [16] Overexpression of cholecystokinin-B/gastrin receptor gene in the stomach of naturally occurring cholecystokinin-A receptor gene knockout rats
    Miyasaka, K
    Kanai, S
    Ohta, M
    Jimi, A
    Kono, A
    Funakoshi, A
    DIGESTION, 1998, 59 (01) : 26 - 32
  • [17] Evaluation of the specificity and potency of a series of cholecystokinin-B/gastrin receptor antagonists in vivo
    Ding, XQ
    Hakanson, R
    PHARMACOLOGY & TOXICOLOGY, 1996, 79 (03): : 124 - 130
  • [18] Interspecies polymorphisms confer constitutive activity to the Mastomys cholecystokinin-B/gastrin receptor
    Schaffer, K
    McBride, EW
    Beinborn, M
    Kopin, AS
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (44) : 28779 - 28784
  • [19] Radiolabeled peptides for targeting cholecystokinin-B/gastrin receptor-expressing tumors
    Behr, TM
    Jenner, N
    Béhé, M
    Angerstein, C
    Gratz, S
    Raue, F
    Becker, W
    JOURNAL OF NUCLEAR MEDICINE, 1999, 40 (06) : 1029 - 1044
  • [20] Preclinical development of cholecystokinin-B/gastrin-receptor binding peptides.
    Behr, TM
    Behe, M
    Jenner, N
    Angerstein, C
    Gratz, S
    Becker, W
    JOURNAL OF NUCLEAR MEDICINE, 1999, 40 (05) : 104P - 104P